Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | Universidade Estadual Paulista (Unesp) | - |
Autor(es): dc.contributor | Federal University of Ceará | - |
Autor(es): dc.contributor | State University of Paraíba | - |
Autor(es): dc.creator | Oshiro-Júnior, João A. [UNESP] | - |
Autor(es): dc.creator | Rodero, Camila [UNESP] | - |
Autor(es): dc.creator | Hanck-Silva, Gilmar [UNESP] | - |
Autor(es): dc.creator | Sato, Mariana R. [UNESP] | - |
Autor(es): dc.creator | Alves, Renata Carolina [UNESP] | - |
Autor(es): dc.creator | Eloy, Josimar O. | - |
Autor(es): dc.creator | Chorilli, Marlus [UNESP] | - |
Data de aceite: dc.date.accessioned | 2022-02-22T00:31:05Z | - |
Data de disponibilização: dc.date.available | 2022-02-22T00:31:05Z | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2019-12-31 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.2174/0929867325666181009120610 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/200570 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/200570 | - |
Descrição: dc.description | Stimuli-responsive drug-delivery nanocarriers (DDNs) have been increasingly reported in the literature as an alternative for breast cancer therapy. Stimuli-responsive DDNs are developed with materials that present a drastic change in response to intrinsic/chemical stimuli (pH, redox and enzyme) and extrinsic/physical stimuli (ultrasound, Near-infrared (NIR) light, magnetic field and electric current). In addition, they can be developed using different strategies, such as functionalization with signaling molecules, leading to several advantages, such as (a) improved pharmaceutical properties of liposoluble drugs, (b) selectivity with the tumor tissue decreasing systemic toxic effects, (c) controlled release upon different stimuli, which are all fundamental to improving the therapeutic effectiveness of breast cancer treatment. Therefore, this review summarizes the use of stimuli-responsive DDNs in the treatment of breast cancer. We have divided the discussions into intrinsic and extrinsic stimuli and have separately detailed them regarding their definitions and applications. Finally, we aim to address the ability of these stimuli-responsive DDNs to control the drug release in vitro and the influence on breast cancer therapy, evaluated in vivo in breast cancer models. | - |
Descrição: dc.description | Department of Drugs and Medicines Faculdade de Ciências Farmacêuticas UNESP-Univ. Estadual Paulista, Campus Araraquara | - |
Descrição: dc.description | College of Pharmacy Dentistry and Nursing Department of Pharmacy Federal University of Ceará | - |
Descrição: dc.description | Graduation Program in Pharmaceutical Sciences State University of Paraíba | - |
Descrição: dc.description | Department of Drugs and Medicines Faculdade de Ciências Farmacêuticas UNESP-Univ. Estadual Paulista, Campus Araraquara | - |
Formato: dc.format | 2494-2513 | - |
Idioma: dc.language | en | - |
Relação: dc.relation | Current Medicinal Chemistry | - |
???dc.source???: dc.source | Scopus | - |
Palavras-chave: dc.subject | Breast cancer treatment | - |
Palavras-chave: dc.subject | Extrinsic/physical stimuli | - |
Palavras-chave: dc.subject | Intrinsic/chemical stimuli | - |
Palavras-chave: dc.subject | Liposoluble drugs | - |
Palavras-chave: dc.subject | Near-infrared light (NIR) | - |
Palavras-chave: dc.subject | Stimuli-responsive drug delivery nanocarriers | - |
Título: dc.title | Stimuli-responsive drug delivery nanocarriers in the treatment of breast cancer | - |
Tipo de arquivo: dc.type | livro digital | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: